Song Wang
- Cancer Research top 10%
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 5
- Nephrology top 5%
- Oncology top 10%
- Colorectal Cancer Surgical Treatments 8
- Colorectal Cancer Treatments and Studies 5
- Pancreatic and Hepatic Oncology Research 4
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 11
- Biomaterials top 10%
-
- Gastric Cancer Management and Outcomes 7
-
- Colorectal and Anal Carcinomas 5
- Cited by
- Cancer ResearchNephrologyOncology
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Song Wang
108 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 135
- Cancer Research 291
- Nephrology 118
- Oncology 404
- Biomedical Engineering 539
- Biomaterials 158
Countries citing papers authored by Song Wang
This map shows the geographic impact of Song Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Song Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Song Wang more than expected).
Fields of papers citing papers by Song Wang
This network shows the impact of papers produced by Song Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Song Wang. The network helps show where Song Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Song Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 6 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 42 | |
| 10 | 2020 | 5 | |
| 11 | 2020 | 8 | |
| 12 | 2019 | 49 | |
| 13 | 2019 | 18 | |
| 14 | 2019 | 105 | |
| 15 | [Trend analysis of morbidity and mortality of colorectal cancer in China from 1988 to 2009]. | 2018 | 3 |
| 16 | 2018 | 31 | |
| 17 | Impact of Interleukin-28B Polymorphism on Response to Treatment in Chinese Hepatitis C Patients | 2012 | 1 |
| 18 | Prevention of Heparin on CRI and CRT in Oncology Patients:A Systematic Review of the Effectiveness | 2011 | 1 |
| 19 | 2011 | 1 | |
| 20 | [A preliminary study of stenting followed by laparoscopic surgery for obstructing left-sided colon cancer]. | 2011 | 15 |
About Song Wang
Song Wang is a scholar working on Oncology, Cancer Research and Nephrology, having authored 114 papers that have together received 2.2k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (11 papers), Colorectal Cancer Surgical Treatments (8 papers), Gastric Cancer Management and Outcomes (7 papers), Colorectal and Anal Carcinomas (5 papers), Colorectal Cancer Treatments and Studies (5 papers), MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Cancer Research (291 citations), Nephrology (118 citations) and Oncology (404 citations). Song Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Youqing Shen, Bing Yu, Hailin Cong, Xiaojuan Li, Shuwen Liu, Xiangzhou Zeng, Zheng Jiang, Xishan Wang, Adeel Ahmed and Lei Tao.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.